Pandemic-response adenoviral vector and RNA vaccine manufacturing.

Kis, Zoltán; Tak, Kyungjae; Ibrahim, Dauda; Papathanasiou, Maria M; Chachuat, Benoît; Shah, Nilay; Kontoravdi, Cleo.

Afiliação

Kis Z; The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK. z.kis@sheffield.ac.uk.
Tak K; Department of Chemical and Biological Engineering, The University of Sheffield, Mappin Street, Sheffield, S1 3JD, UK. z.kis@sheffield.ac.uk.
Ibrahim D; The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Papathanasiou MM; The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Chachuat B; The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Shah N; The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Kontoravdi C; The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.

NPJ Vaccines ; 7(1): 29, 2022 Mar 02.

Article em En | MEDLINE | ID: mdl-35236838

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article